128 results on '"De Mattia, G"'
Search Results
2. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
3. l-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients
4. Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release
5. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes
6. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)
7. Salt-sensitivity is associated with a hyperinsulinaemic and hyperglycaemic response to atrial natriuretic peptide infusion in human essential hypertension
8. Early nocturnal blood pressure changes in diabetic autonomic neuropathy assessed by Fourier series
9. Ambulatory blood pressure recording in diabetic patients with abnormal responses to cardiovascular autonomic function tests
10. A case of facio-scapulo-humeroperoneal myopathy with inflammatory changes. Preliminary data on distribution of mononuclear cells in muscle tissue
11. COVID-19 pandemic: an Italian single institution's experience and lessons learned by public health residents' workforce.
12. Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes
13. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database
14. CAMURATI-ENGELMANN DISEASE: EFFICACY OF ANTI-TNFALFA TREATMENT.
15. WORTH'S DISEASE (LRP5 HIGH-BONE-MASS): CASE REPORT AND REVIEW OF THE LITERATURE.
16. ECTOPIC ARTICULAR CALCIFICATIONS AND ARTERIAL OCCLUSIVE DISEASE DUE TO 5-NUCLEOTIDASE DEFICIENCY.
17. VEGF is inversely correlated to renal function in patients with type 2 diabetes
18. Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes
19. Quality of virgin oil as influenced by origin area
20. Relationship between insulin resistance and nonmodulating hypertension
21. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependence diabetes mellitus
22. Obesity, hypertension and endothelial activation
23. Polyol pathway activation and glutathion redox staus in non-insulin-dependent diabetic patients
24. Endothelial dysfunction in salt sensitive hypertension
25. Endogenous insulin modulates circulating endothelin-1 concentrations in human
26. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition
27. Atrial natriuretic factor in hypertensive and normotensive diabetic patients
28. Salt-sensitivity is associated with a hyperinsulinaemic and hyperglycaemic response to atrial natriuretic peptide infusion in human essential hypertension
29. Effects of short-time insulin suppression on renal sodium excretion in type II diabetic hypertensives
30. Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk.
31. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies.
32. l-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients M. Cassone Faldetta et al.: L-arginine decreases homocysteine.
33. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
34. Early upregulation of endothelial adhesion molecules in obese hypertensive men.
35. Effect of aprotinin on insulin sensitivity in non-insulin-dependent diabetes mellitus.
36. Plasma endothelin-1 levels in obese hypertensive and normotensive men.
37. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
38. Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage.
39. E037: Plasma homocysteine levels in type 2 normotensive and hypertensive diabetic patients.
40. A008: Endothelial dysfunction and dyslipidemia in essential hypertensive patients.
41. The blockade of the renin system blunts endothelial adhesin expression in vivo.
42. A007: Endothelial activation in obese patients with or without essential hypertension.
43. Human salt-sensitive hypertension is combined to endothelial dysfunction in the absence of overt vascular damage.
44. Plasma and urinary endothelin-1 (ET-1) as distinct markers for glomerular and tubular damage.
45. G13: Endothelial dysfunction in patients with multiple metabolic abnormalities.
46. The great challenge: bone fragility and environment.
47. Anabolic treatment for osteoporosis and fragility fracture risk: one year in review 2024.
48. Lessons Learned from the COVID-19 Vaccination Campaigns in Veneto Region: Population Vaccination Centers as Support for the Traditional Outpatient Model.
49. LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature.
50. Preliminary Clinical and Laser Speckle Contrast Analysis Data on Selexipag Efficacy for the Treatment of Digital Vasculopathy in Systemic Sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.